Can Doug and Gilmore use $7 billion - right now? | SRPT Message Board Posts

Sarepta Therapeutics Inc.

  SRPT website

SRPT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  13815 of 14013  at  7/16/2019 9:49:32 AM  by

schmiggins


 In response to msg 13814 by  schmiggins
view thread

Re: Can Doug and Gilmore use $7 billion - right now?

That Barron's article is pretty good.

"Instead of embarking on a pharmaceutical megamerger, of the sort Barron’s has argued against, Daniel O’Day, Gilead’s new CEO, signed a 10-year deal with longtime collaborator Galapagos (ticker: GLPG) to boost his company’s pipeline of potential treatments.

–– ADVERTISEMENT ––


“I firmly believe [in] the concept that we’ve come up with, the concept of enabling Galapagos with a significant capital infusion for them to further invest in that research and at the same time keeping their independence as a premier European biotech company that allows them to recruit the very best talent, make their own decision and progress programs according to their judgment,” O’Day said on a conference call about the deal.

The back story. Gilead  (GILD) and Galapagos have had a long courtship. Gilead signed a $2 billion deal with Galapagos in 2015, codeveloping an experimental rheumatoid-arthritis drug called filgotinib. Before the new deal, Gilead had a 12.3% ownership stake in Galapagos. The current agreement will increase that stake to 22%.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 140
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...